Michiel Kroesen
Overview
Explore the profile of Michiel Kroesen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsuan Chen Y, Kroesen M, Hoogeman M, Versteegh M, Uyl-de Groot C, Blommestein H
Clin Transl Radiat Oncol
. 2025 Feb;
51:100913.
PMID: 39898329
Objective: In comparison to current standard photon irradiation, proton therapy (PT) significantly reduces dose to the surrounding normal tissue and therefore is expected to reduce toxicity and improve health related...
2.
Miladinovic V, Klaver Y, Krol A, Kroesen M, Verbist B, Habraken S, et al.
Strahlenther Onkol
. 2024 Aug;
200(12):1066-1073.
PMID: 39207463
Background: Chordomas and chondrosarcomas of the skull base are rare, slowly growing malignant bone neoplasms. Despite their radioresistant properties, proton therapy has been successfully used as an adjunct to resection...
3.
Feddersen T, Hernandez-Tamames J, Paulides M, Kroesen M, van Rhoon G, Poot D
Int J Hyperthermia
. 2024 Jul;
41(1):2352545.
PMID: 38991549
Magnetic resonance thermometry (MRT) can measure in-vivo 3D-temperature changes in real-time and noninvasively. However, for the oropharynx region and the entire head and neck, motion potentially introduces large artifacts. Considering...
4.
Oud M, Breedveld S, Rojo-Santiago J, Gizynska M, Kroesen M, Habraken S, et al.
Phys Med Biol
. 2024 Feb;
69(7).
PMID: 38373350
. In head-and-neck cancer intensity modulated proton therapy, adaptive radiotherapy is currently restricted to offline re-planning, mitigating the effect of slow changes in patient anatomies. Daily online adaptations can potentially...
5.
Elbers J, Gunsch P, Debets R, Keereweer S, van Meerten E, Zindler J, et al.
BMC Cancer
. 2023 Jun;
23(1):541.
PMID: 37312053
Background: Radiotherapy (RT) is the standard of care for most advanced head and neck squamous cell carcinoma (HNSCC) and results in an unfavorable 5-year overall survival of 40%. Despite strong...
6.
Oud M, Breedveld S, Gizynska M, Kroesen M, Hutschemaekers S, Habraken S, et al.
Radiother Oncol
. 2022 Sep;
176:68-75.
PMID: 36150418
Background And Purpose: In intensity modulated proton therapy (IMPT), the impact of setup errors and anatomical changes is commonly mitigated by robust optimization with population-based setup robustness (SR) settings and...
7.
Kroesen M, van Holthe N, Sumser K, Chitu D, Vernhout R, Verduijn G, et al.
Cancers (Basel)
. 2021 Dec;
13(23).
PMID: 34885258
(1) Background: Head and neck cancer (HNC) patients with recurrent or second primary (SP) tumors in previously irradiated areas represent a clinical challenge. Definitive or postoperative reirradiation with or without...
8.
Kroesen M, Miladinovic V, Hutschemaekers S, Jacobs J, van der Vos C, Wolf A, et al.
Radiother Oncol
. 2021 Nov;
166:58-64.
PMID: 34843840
Background: Due to its specific physical characteristics, proton irradiation is especially suited for irradiation of chordomas and chondrosarcoma in the axial skeleton. Robust plan optimization renders the proton beam therapy...
9.
van den Bijgaart R, Kroesen M, Brok I, Reijnen D, Wassink M, Boon L, et al.
Oncoimmunology
. 2021 Jan;
9(1):1817653.
PMID: 33457098
Neuroblastoma is a childhood malignancy and in the majority of patients, the primary tumor arises in one of the adrenal glands. Neuroblastoma cells highly express the disialoganglioside GD2, which is...
10.
Kroesen M, Mulder H, van Rhoon G, Franckena M
Front Oncol
. 2020 Jan;
9:1387.
PMID: 31921644
No abstract available.